Role of spindle pole body component 25 in neurodegeneration.
Alzheimer’s disease (AD)
Neurodegeneration
microglia
spindle pole body component 25 (SPC25)
Journal
Annals of translational medicine
ISSN: 2305-5839
Titre abrégé: Ann Transl Med
Pays: China
ID NLM: 101617978
Informations de publication
Date de publication:
Sep 2021
Sep 2021
Historique:
received:
09
07
2021
accepted:
03
09
2021
entrez:
4
11
2021
pubmed:
5
11
2021
medline:
5
11
2021
Statut:
ppublish
Résumé
Aberrant growth and polarization of microglia are critical for pathological initiation and progression of neurodegenerative conditions like Alzheimer's disease (AD). However, the molecular signals that govern the outgrowth of microglia have not yet been fully determined. Spindle pole body component 25 (SPC25) is an important part for forming NDC80 complex, which plays a key role in the assembly of the microtubule-binding domain of kinetochores. Nevertheless, the role of SPC25 in microglial growth during neurodegeneration has not been described before, and was thus addressed in the current study. We generated an adeno-associated virus (AAV) serotype PHP.B carrying short hairpin RNA (shRNA) for SPC25 (shSPC25) under a microglia-specific TMEM119 promoter (AAV-pTMEM-shSPC25). Serotype PHP.B allowed the virus to cross blood-brain barrier, while TMEM119 promoter allowed specific targeting microglia in vitro and in vivo. We intravenously administrated AAV-pTMEM-shSPC25 to AD-prone APP/PS1 male and female mice and determined this effect on microglia proliferation and mouse behavior. Depletion of SPC25 did not alter polarization of microglia cell polarization in vitro. On the other hand, AD-prone APP/PS1 mice that had received AAV-pTMEM-shSPC25 significantly decreased SPC25 levels in microglia and attenuated microglia proliferation, resulting in significant improvement of the performance of the mice in behavior tests. Specific depletion of SPC25 in microglia may prevent AD development through suppression of microglia outgrowth. SPC25 may be a promising novel target for preventing AD through microglia.
Sections du résumé
BACKGROUND
BACKGROUND
Aberrant growth and polarization of microglia are critical for pathological initiation and progression of neurodegenerative conditions like Alzheimer's disease (AD). However, the molecular signals that govern the outgrowth of microglia have not yet been fully determined. Spindle pole body component 25 (SPC25) is an important part for forming NDC80 complex, which plays a key role in the assembly of the microtubule-binding domain of kinetochores. Nevertheless, the role of SPC25 in microglial growth during neurodegeneration has not been described before, and was thus addressed in the current study.
METHODS
METHODS
We generated an adeno-associated virus (AAV) serotype PHP.B carrying short hairpin RNA (shRNA) for SPC25 (shSPC25) under a microglia-specific TMEM119 promoter (AAV-pTMEM-shSPC25). Serotype PHP.B allowed the virus to cross blood-brain barrier, while TMEM119 promoter allowed specific targeting microglia in vitro and in vivo. We intravenously administrated AAV-pTMEM-shSPC25 to AD-prone APP/PS1 male and female mice and determined this effect on microglia proliferation and mouse behavior.
RESULTS
RESULTS
Depletion of SPC25 did not alter polarization of microglia cell polarization in vitro. On the other hand, AD-prone APP/PS1 mice that had received AAV-pTMEM-shSPC25 significantly decreased SPC25 levels in microglia and attenuated microglia proliferation, resulting in significant improvement of the performance of the mice in behavior tests.
CONCLUSIONS
CONCLUSIONS
Specific depletion of SPC25 in microglia may prevent AD development through suppression of microglia outgrowth. SPC25 may be a promising novel target for preventing AD through microglia.
Identifiants
pubmed: 34733984
doi: 10.21037/atm-21-4064
pii: atm-09-18-1432
pmc: PMC8506722
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1432Informations de copyright
2021 Annals of Translational Medicine. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://dx.doi.org/10.21037/atm-21-4064). The authors have no conflicts of interest to declare.
Références
Oncol Lett. 2018 Apr;15(4):5712-5720
pubmed: 29552205
Biochem Biophys Res Commun. 2018 Jun 12;500(4):937-943
pubmed: 29709477
J Alzheimers Dis. 2019;70(3):659-666
pubmed: 31256143
J Alzheimers Dis. 2019;67(1):149-157
pubmed: 30475765
Brain Behav Immun. 2020 Jan;83:180-191
pubmed: 31604143
Chromosome Res. 2011 Apr;19(3):377-91
pubmed: 21311965
Mol Ther. 2019 Apr 10;27(4):700-704
pubmed: 30842039
Mol Ther. 2017 Dec 6;25(12):2727-2742
pubmed: 28882452
J Histochem Cytochem. 2007 Jul;55(7):687-700
pubmed: 17341475
Dement Geriatr Cogn Disord. 2016;41(3-4):220-32
pubmed: 27160163
Cell Rep. 2017 Oct 10;21(2):366-380
pubmed: 29020624
Hum Mol Genet. 2004 Jan 15;13(2):159-70
pubmed: 14645205
Front Aging Neurosci. 2018 Nov 20;10:378
pubmed: 30515090
J Alzheimers Dis. 2019;68(1):323-337
pubmed: 30775984
Nat Rev Neurosci. 2018 Oct;19(10):622-635
pubmed: 30206328
Aging (Albany NY). 2018 Nov 8;10(11):3273-3282
pubmed: 30408771
PLoS One. 2019 Nov 14;14(11):e0225206
pubmed: 31725765
Adv Exp Med Biol. 2018;1099:77-91
pubmed: 30306516